According to The Insight Partners study on the Radiation Oncology Market is observing significant growth owing to the ...

Bertram Yuh, MD, MISM, MSHCPM, discussed how single-port robotic surgery has changed treatment paradigms for patients with ...

The Swiss market recently demonstrated resilience by rebounding from a weak start, buoyed by the European Central Bank's interest rate cut to 3.25%, which helped lift the SMI index by 0.91% to close ...

On September 30, 2024, Empery Asset Management, LP (Trades, Portfolio) made a significant addition to its investment ...

Expert oncologists and advanced technology deliver personalised treatment ...

NANTES, France, October 17, 6:00pm CET - SA (ISIN: FR0012127173; Mnemo: OSE), today announced it will be presenting its ...

Malcolm Ethridge, Capital Area Planning Group managing partner, joined CNBC to talk about where the market could go and his ...

Okomera announces Bpifrance funding to develop and standardize novel CRISPR screening assay to accelerate drug discovery in ...

AKT1 E17K mutation is a clinically validated oncogene that impacts greater than 40,000 cancer patients per year in the United States, with the highest prevalence in breast, endometrial, and prostate ...

We recently compiled a list of 10 High Growth NASDAQ Stocks That Are Profitable in 2024. In this article, we will look at ...